BioMarin EVP Gregory R. Friberg reports sale of $302,710.511 in common shares
BMRN•BioMarin Pharmaceutical EVP and Chief R&D Officer Gregory R. Friberg sold 5,147 common shares on Nov. 18, 2026, at $58.813 per share, leaving direct holdings of 42,585 shares.
1. Share sale
Gregory R. Friberg sold 5,147 BioMarin Pharmaceutical common shares on Nov. 18, 2026, at $58.813 per share. The Form 4, dated Nov. 19, reported direct holdings of 42,585 shares after the sale.




